Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK)

Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Amount: 50 µg
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Delivery Format: Freeze-dried in glass vial
Application(s): T-cell immunity
Condition(s)/Topic(s): Control, Infectious mononucleosis, Opportunistic infections, Cytomegalovirus disease
Standard Delivery Time: 2-5 days

Visit our webpage for more information on Peptide Tools to Study CMV.

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool and MHC Dextramer with your peptide as a set!